Topical drops for ocular cystinosis gains approval

• Posted on: Aug 26 2020
• By: Saratoga Opthalmology
• Leave a response

Recordati Rare Diseases has announced FDA clearance of their cysteamine 0.37% eye drops (Cystadrops) for treating cystinosis-related corneal crystal deposits.
Source: AAO

Posted in: Uncategorized